Key Highlights

● Intuitive Surgical closed at $426.70 on October 16, trading below the analyst target.

● The consensus 12-month price target is $478.53, implying about 12.2% upside.

● Analysts are split 26 Buy, 7 Hold, and 1 Sell on the stock.

● Targets range from $324 to $685 across 34 analysts.

Intuitive Surgical, Inc. (NASDAQ:ISRG) closed at $426.70 on October 16, 2026, according to market data. The stock is a constituent of the Nasdaq-100 and trades on the Nasdaq. The consensus analyst price target is $478.53, which is 12.2% above the latest close, implying 12.2% upside. The shares are drawing attention this week because of fresh analyst activity and upcoming earnings: the next results are expected on October 20, 2026.

What Is the Latest Analyst Price Target?

The mean consensus target is $478.53 across 34 analysts, with a median of $484.00. Individual forecasts range from a low of $324.00 to a high of $685.00. Measured against the 16 October close of $426.70, the consensus target suggests 12.2% upside. The analyst data on the source page was last updated on October 13, 2026. These figures are forecasts, not guarantees, and different data providers can show slightly different consensus numbers because of timing and methodology.

What Are Analysts Saying?

The overall consensus rating is Buy, with the ratings split as 26 Buy (18 Strong Buy, 8 Buy), 7 Hold, 1 Sell (Strong Sell). Recent broker actions include the following. Mizuho (13 Oct) kept a Hold rating but raised its target to $415 from $400; UBS (13 Oct) maintained Buy at $500; BTIG (12 Oct) maintained Buy and lowered its target to $454 from $469; Leerink Partners (12 Oct) reiterated Buy and raised its target to $473 from $454; and Piper Sandler (7 Oct) maintained Buy at $470.

The target range is unusually wide ($324 to $685), indicating a lack of agreement among analysts, and some brokers (such as HSBC, which downgraded to Hold earlier in the summer) remain cautious.

What Could Help the Stock Reach the Price Target?

If the consensus proves accurate, the shares would need to close the gap to $478.53. Several factors could support that outcome. Company developments are one: Barclays initiated coverage with an Overweight rating in early October, and the shares were reported to have fallen 12.5% at one point earlier in the summer. Third-quarter results are due on October 20, 2026.

Beyond this, results that meet or exceed expectations, firm guidance and stable sector conditions would typically support analyst estimates and could encourage further target upgrades. Equally, a broadly supportive market backdrop can narrow the gap between price and targets. None of these outcomes is assured.

What Could Prevent the Stock Reaching the Target?

Analyst targets are opinions about a twelve-month horizon and are frequently revised. Earnings that fall short of expectations, weaker guidance, changes in interest rates, regulatory or policy shifts and wider market volatility could all cause the shares to underperform the consensus. The spread between the lowest target ($324.00) and highest target ($685.00) shows that professional forecasters do not agree on fair value. Investors should also note that consensus figures can lag recent events, so the numbers cited here may already have been overtaken by newer broker notes.

What Should Investors Watch Next?

The key event is the next earnings report, expected on October 20, 2026. Investors may wish to watch management commentary and guidance, any changes to broker ratings and targets following the results, and the direction of the consensus mean and median in the weeks ahead. Any further company announcements, such as acquisitions, dividends or leadership changes, may also influence sentiment.

The Target Still Leads

On the verified figures, Intuitive Surgical, Inc. (ISRG) closed at $426.70 on October 16, 2026, while the analyst consensus target of $478.53 suggests 12.2% upside, with a Buy consensus rating across 34 analysts.